To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if there are pharmacokinetic interactions between
the NRTI 3TC and ABV, and the TDF nucleotide. For this purpose, the intracellular and plasma
levels of 3TC and ABV will be compared in patients given these nucleosides with TDF and 30
days after the interruption of the TDF.
Phase:
Phase 4
Details
Lead Sponsor:
Germans Trias i Pujol Hospital
Collaborators:
Fundacio Lluita Contra la SIDA Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia